Russia’s Skolkovo Foundation and UK Trade & Investment invite you to attend a two-day event focusing on the opportunities in Russia’s fast growing pharmaceutical market. The event will take place at Skolkovo Innovation Centre - Russia’s leading Science Park - on 24-25 May 2016. Top biopharmaceutical companies, leading biotech associations, contract research & manufacturing organisations from both the UK and Russia will participate.
Session 1. Opportunities for Novel Drug Development in the UK
Moderator: German Inozemtsev, Editor-in-chief of Pharmvestnik
“Going Global: The UK's Life Sciences Offer”
The Centre for Process Innovation and the National Biologics Manufacturing Centre – Innovation in Biopharmaceutical Manufacture
“Сlinical research in the UK: International success built on national excellence”
The United Kingdom (UK) has been a leader of scientific and medical advances for many decades. With a population of circa 65 million, the UK offers a ready made research facilities and willing market for successful medicines.
“Global Drug Development Opportunities: Russian Pharma Perspective”
Panel discussion “Novel Drug Development in Russia and UK: leading companies’ experience”
Irina Bagriantseva, UKTI Lead Inward Investment Adviser, will be available during the lunch break provide general information on how to set up a business in the UK.
“ClinTec Innovative Approach ”
ClinTec has a wealth of expertise in managing clinical trials in all major therapeutic categories including oncology, rare diseases, neurology, autoimmune diseases and diabetes.
A Masters degree course was innovated in collaboration between Edinburgh Napier University and ClinTec International to support the development of clinical research staff throughout the world, and now endorsed by the ATC. The Masters programme is accessible globally and has an enrolment of students from 14 countries.
ClinTec offers various courses through its Academy of Clinical Research Excellence (ACRE)
Session 2. UK Pharmaceutical Companies in Russia
Moderator: Kristina Khodova, Skolkovo Foundation
“What can science do? AstraZeneca as a pioneer in drug development for lung cancer”
“GSK as the part of Russian Clinical Landscape and Russia in GSK universe”
Session 3. Opportunities for Novel Drug Development in Russia
“Russian Pharma & Biotech Market”
«Current state and development prospects of the local pharmaceuticals market. The view of pharmaceutical manufactures.”
The Russian Venture Capital Market
Minister Counsellor Prosperity British Embassy Moscow
Vice-President of Skokovo Foundation. Head of Biological and Medical Technology Cluster
Director of UKTI Russia, UK Trade & Investment
Editor-in-Chief of the research and information paper Pharmaсeutical Newsletter
UK BIA, Medicines Manufacturing Industry Partnership (MMIP), UKTI Life Sciences Organisation
UKTI Lead Inward Investment Adviser
Centre for Process Innovation and the National Biologics Manufacturing Centre
СEO, CCA Clinical Research, Clinical & Contract Research Association (CCRA)
Medical Director, R-Pharm
Executive Director of Association of Сlinical Trials Organizations (ACTO)
Deputy Director, co-founder at Quantum Pharmaceuticals and Quantum Age, Business Development Director, co-founder at GERO MS Law, MS Finances
Partner RBV Capital
Senior Director Central and Eastern Europe, CIS countries, ClinTec International
Astra Zeneca, Global Clinical Lead, Oncology
Regional Head for Russia, Middle East & Africa, Global Clinical Sciences and Operations
Head of Oncology/Immunology Projects, Biomedical Cluster, Skolkovo Foundation
Investment Director RBV Capital
Head of Team (Technology, Health, Environment & Agriculture)
Trade and Investment Adviser (Healthcare & Medical, Life Sciences) UK Trade & Investment
CEO, Association of RussianPharmaceutical Manufacturers
UKTI Russia will organise one-to-ones with top Russian biopharmaceuticals companies during the partnering session. Further networking opportunities will include an evening reception at the UK Ambassador’s Residence in Moscow.
Participation in the event is FREE OF CHARGE, but participants will be responsible for their own travel and hotel expenses
Ekaterina Zhuravleva,Trade and Investment AdviserТел: +7 (495) 956-74-62E: Ekaterina.Zhuravleva@fco.gov.uk.
Kristina Khodova,Skolkovo FoundationТел: +7 (495) 956-00-33 (ext. 2522)E: KKhodova@sk.ru
Все материалы сайта доступны по лицензии: Creative Commons Attribution 4.0 International
Политика обработки персональных данных